Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesisLeena Gandhi, Kate L McNamara, Danan Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerKristin A Spivey, Jacqueline Banyard, Luisa M Solis, et al.
JCO Precision Oncology|March 21, 2024
Identifying Oncology Clinical Trial Candidates Using Artificial Intelligence Predictions of Treatment Change: A Pilot Implementation StudyKenneth L Kehl, Tali Mazor, Pavel Trukhanov, et al.
Clinical Lung Cancer|March 26, 2017
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage DiseaseMark A Socinski, Frederic J Kaye, David R Spigel, et al.
ESMO Open|July 19, 2018
Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancerSai-Hong Ignatius Ou, Mark A Socinski, Shirish Gadgeel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2025
Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 studyKei Muro, Trevor Feinstein, Joaquina Baranda, et al.
Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer PatientsCloud P Paweletz, Adrian G Sacher, Chris K Raymond, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)Mark M Awad, Quincy S-C Chu, Leena Gandhi, et al.
Pageof 7